Published: 2018-02-22

Race specific nomograms: time for change?

Pearl Mary Varughese, Nishanth Rajan, Manikandan Mani, Lalitha Krishnan


Background: Hyperbilirubinemia is a common problem in neonates. Because of the genetic differences in bilirubin metabolism, an hour specific nomogram is better in each geographical location. No studies in South India for creation and validation of a nomogram for significant hyperbilirubinemia. The aim of this study was to create and validate a bilirubin nomogram in South Indian infants.

Methods: A prospective cross-sectional study. The data was collected in 2 parts, over 18 months (264 infants) and 20 months (450 infants) respectively. Babies with established direct hyperbilirubinemia, polycythemia, hypothyroidism, culture proven sepsis, major congenital anomalies and jaundice on day 1 of life were excluded. For all babies, cord bilirubin (for first set of infants), total serum bilirubin values were sent at 24 hours of life and at the time of discharge. An hour specific nomogram was created with 834 bilirubin values (first set of data). The predictive ability of this nomogram and Bhutani nomogram were tested and compared using 972 total serum bilirubin values (second set of data)

Results: A nomogram was created with serum bilirubin values from the first set of infants and validated it with the serum bilirubin values from the second set of infants. Bhutani nomogram was also validated. Comparing with Bhutani nomogram, our nomogram was better in predicting significant hyperbilirubinemia in our population.

Conclusions: Discharging neonates without risk assessment for severe hyperbilirubinemia may be dangerous. A nomogram generated and validated with our data is an accurate tool for predicting significant hyperbilirubinemia in our population.



Nomogram, Phototherapy, Significant hyperbilirubinemia, Serum bilirubin

Full Text:



Maisels MJ. Managing the jaundiced newborn: a persistent challenge. CMAJ Can Med Assoc J. 2015;187(5):335-43.

Cloherty JP. Manual of neonatal care. 7th edition. Wolter Kluwer; 2012:1024.

Kondekar A, Kondekar S. Unconjugated bilirubin from cord blood; an indicator for prophylactic phototherapy. Pediatr Rev Int J Pediatr Res. 2016;3(04).

Romagnoli C, Tiberi E, Barone G, Curtis MD, Regoli D, Paolillo P, et al. Development and validation of serum bilirubin nomogram to predict the absence of risk for severe hyperbilirubinemia before discharge: a prospective, multicentre study. Ital J Pediatr. 2012;38:6.

Wang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatr. 2004;114(2):372-6.

Gupta P, Malhotra S, Singh DK, Dua T. Length of postnatal stay in healthy newborns and re-hospitalization following their early discharge. Indian J Pediatr. 2006;73(10):897-900.

Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum Bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatr. 1999;103(1):6-14.

Fay DL, Schellhase KG, Suresh GK. Bilirubin screening for normal newborns: a critique of the hour-specific bilirubin nomogram. Pediatr. 2009;124(4):1203-5.

Mishra S, Chawla D, Agarwal R, Deorari AK, Paul VK. Transcutaneous bilirubin levels in healthy term and late preterm Indian neonates. Indian J Pediatr. 2010;77(1):45-50.

Sarici SÜ, Serdar MA, Korkmaz A, Erdem G, Oran O, Tekinalp G, et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatr. 2004;113(4):775-80.

Maisels MJ, Deridder JM, Kring EA, Balasubramaniam M. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol Off J Calif Perinat Assoc. 2009;29(9):612-7.

Keren R, Bhutani V, Luan X, Nihtianova S, Cnaan A, Schwartz J. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child. 2005;90(4):415-21.

Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant ≥35 weeks’ gestation: an update with clarifications. Pediatr. 2009;124(4):1193-8.

Lavanya KR, Jaiswal S, Reddy P, Murki S. Predictors of significant jaundice in late preterm infants. Indian Pediatr. 2012;49(9):717-20.

Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154(11):1140-7.

Ip S, Chung M, Kulig J, O’Brien R, Sege R, Glicken S, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatr. 2004;114(1):e130-53.

Slaughter J, Annibale D, Suresh G. False-negative results of pre-discharge neonatal bilirubin screening to predict severe hyperbilirubinemia: a need for caution. Eur J Pediatr. 2009;168(12):1461-6.

Huang HC, Yang HI, Chang YH, Chang RJ, Chen MH, Chen CY, et al. Model to predict hyperbilirubinemia in healthy term and near-term newborns with exclusive breast feeding. Pediatr Neonatol. 2012;53(6):354-8.

Yu Z, Han S, Wu J, Li M, Wang H, Wang J, et al. Validation of transcutaneous bilirubin nomogram for identifying neonatal hyperbilirubinemia in healthy Chinese term and late-preterm infants: a multicenter study. J Pediatr (Rio J). 2014;90(3):273-8.

Kolman KB, Mathieson KM, Frias C. A comparison of transcutaneous and total serum bilirubin in newborn Hispanic infants at 35 or more weeks of gestation. J Am Board Fam Med JABFM. 2007;20(3):266-71.

Akahira-Azuma M, Yonemoto N, Ganzorig B, Mori R, Hosokawa S, Matsushita T, et al. Validation of a transcutaneous bilirubin meter in Mongolian neonates: comparison with total serum bilirubin. BMC Pediatr. 2013;13:151.